journal article·2015-02-04

Local and Sustained Gene Delivery in Silica-Collagen Nanocomposites

Xiaolin Wang, Christophe Hélary, Thibaud Coradin

Publisher page

Abstract

Local delivery of biomolecules from hydrogels is highly challenging because of their rapid diffusion and degradation. Gene therapy represents an alternative that allows for the prolonged production of proteins by transfected cells. In this study, we have developed nanocomposites consisting of DNA-polyethylenimine-silica nanoparticle complexes coencapsulated with fibroblasts within collagen hydrogels. Through the modulation of the particle size and polyethylenimine molecular weight, it was possible to achieve "in-gel" transfection permitting the sustained production of biomolecules from hydrogels over 1 week. Alternative configurations consisting of particle addition to cellularized gels and cell culture in the presence of complex-containing hydrogels were also investigated. These studies demonstrated that particle encapsulation limits DNA and silica dissemination outside the collagen hydrogels. They also show the key role of cell proliferation within collagen hydrogels on the transfection efficiency. Such nanocomposites therefore constitute promising materials for the development of novel gene delivery systems to promote tissue repair.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · Bone Tissue Engineering Materials · Silk-based biomaterials and applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Sorbonne Universités, UPMC Univ Paris 06, CNRS, Collège de France, UMR 7574, Chimie de la Matière Condensée de Paris, F-75005, Paris, France

Funding

China Scholarship Council

References (49)

Show source-provided references
1. Eming S. A. · J. Invest. Dermatol. · 2007 · 127 · 51410.1038/sj.jid.5700701 ↗
2. Boateng J. S. · J. Pharm. Sci. · 2008 · 97 · 289210.1002/jps.21210 ↗
3. Menke N. B. · Clin. Dermatol. · 2007 · 25 · 1910.1016/j.clindermatol.2006.12.005 ↗
4. Bowen-Pope D. F. · Blood · 1984 · 64 · 45810.1182/blood.V64.2.458.458 ↗
5. Eppler S. M. · Clin. Pharmacol. Ther. · 2002 · 72 · 2010.1067/mcp.2002.126179 ↗
6. Cam C. · Curr. Opin. Biotechnol. · 2013 · 24 · 85510.1016/j.copbio.2013.04.007 ↗
7. Place E. S. · Nat. Mater. · 2009 · 8 · 45710.1038/nmat2441 ↗
8. Conwell C. C. · Adv. Genet. · 2005 · 53 · 110.1016/S0065-2660(05)53001-3 ↗
9. Eming S. A. · Clin. Dermatol. · 2007 · 25 · 7910.1016/j.clindermatol.2006.09.011 ↗
10. Sun J. Y. · Gene Ther. · 2003 · 10 · 96410.1038/sj.gt.3302039 ↗
11. Xia T. · ACS Nano · 2009 · 3 · 327310.1021/nn900918w ↗
12. Dufes C. · Adv. Drug Delivery Rev. · 2005 · 57 · 217710.1016/j.addr.2005.09.017 ↗
13. Mintzer M. A. · Chem. Soc. Rev. · 2011 · 40 · 17310.1039/B901839P ↗
14. Boussif O. · Proc. Natl. Acad. Sci. U. S. A. · 1995 · 92 · 729710.1073/pnas.92.16.7297 ↗
15. Remy J. S. · Adv. Drug Delivery Rev. · 1998 · 30 · 8510.1016/S0169-409X(97)00109-9 ↗
16. Petersen H. · Bioconjugate Chem. · 2002 · 13 · 84510.1021/bc025529v ↗
17. Hu C. · Bioconjugate Chem. · 2010 · 21 · 83610.1021/bc900374d ↗
18. Mamaeva V. · Adv. Drug Delivery Rev. · 2013 · 65 · 68910.1016/j.addr.2012.07.018 ↗
19. Meng H. · ACS Nano · 2011 · 5 · 413110.1021/nn200809t ↗
20. Kim T.-W. · ACS Nano · 2010 · 4 · 360
21. Kim M.-H. · ACS Nano · 2011 · 5 · 356810.1021/nn103130q ↗
22. Rosenholm J. M. · Chem. Mater. · 2007 · 20 · 112610.1021/cm7021328 ↗
23. Buchman Y. K. · Bioconjugate Chem. · 2013 · 24 · 207610.1021/bc4004316 ↗
24. Luo D. · J. Controlled Release · 2004 · 95 · 33310.1016/j.jconrel.2003.11.019 ↗
25. Shea L. D. · Nat. Biotechnol. · 1999 · 17 · 55110.1038/9853 ↗
26. Grinnell F. · Trends Cell Biol. · 2003 · 13 · 26410.1016/S0962-8924(03)00057-6 ↗
27. Grinnell F. · Annu. Rev. Cell Dev. Biol. · 2010 · 26 · 33510.1146/annurev.cellbio.042308.113318 ↗
28. De Laporte L. · Adv. Drug Delivery Rev. · 2007 · 59 · 29210.1016/j.addr.2007.03.017 ↗
29. Gojgini S. · Mol. Pharmaceutics · 2011 · 8 · 158210.1021/mp200171d ↗
30. Desimone M. F. · ACS Appl. Mater. Interfaces · 2011 · 3 · 383110.1021/am2009844 ↗
31. Alvarez G. S. · J. Mater. Chem. B · 2014 · 2 · 466010.1039/c4tb00327f ↗
32. Meszaros R. · Langmuir · 2003 · 19 · 997710.1021/la0352218 ↗
33. Wang Z. J. · ACS Nano · 2009 · 3 · 411010.1021/nn9012274 ↗
34. Rejman J. · Biochem. J. · 2004 · 377 · 15910.1042/bj20031253 ↗
35. Wightman L. · J. Gene Med. · 2001 · 3 · 36210.1002/jgm.187 ↗
36. Godbey W. T. · J. Controlled Release · 1999 · 60 · 14910.1016/S0168-3659(99)00090-5 ↗
37. Godbey W. T. · Gene Ther. · 1999 · 6 · 138010.1038/sj.gt.3300976 ↗
38. Felgner P. L. · Proc. Natl. Acad. Sci. U. S. A. · 1987 · 84 · 741310.1073/pnas.84.21.7413 ↗
39. Quignard S. · Biomaterials · 2012 · 33 · 443110.1016/j.biomaterials.2012.03.004 ↗
40. Quignard S. · Biomater. Sci. · 2014 · 2 · 48410.1039/C3BM60214A ↗
41. Powers J. G. · Dermatol. Ther. · 2013 · 26 · 19710.1111/dth.12055 ↗
42. Slaughter B. V. · Adv. Mater. · 2009 · 21 · 330710.1002/adma.200802106 ↗
43. Chen K. H. · J. Mater. Chem. · 2012 · 22 · 2200510.1039/c2jm34364a ↗
44. Ferrari M. · Nat. Nanotechnol. · 2008 · 3 · 13110.1038/nnano.2008.46 ↗
45. Kettiger H. · Int. J. Nanomed. · 2013 · 8 · 3255
46. Gao F. · J. Phys. Chem. B · 2009 · 113 · 179610.1021/jp807956r ↗
47. Holladay C. · J. Controlled Release · 2009 · 136 · 22010.1016/j.jconrel.2009.02.006 ↗
48. Jang J. H. · Mol. Ther. · 2005 · 12 · 47510.1016/j.ymthe.2005.03.036 ↗
49. Helary C. · Biomaterials · 2010 · 31 · 48110.1016/j.biomaterials.2009.09.073 ↗